Search

everythinglearnresearchcommunity

for

Search:↓

Research 10 of 338

1. Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome Gynecological Endocrinology · 2024 · 11 citations
2. Potential role and therapeutic interests of myo-inositol in metabolic diseases Biochimie · 2013 · 369 citations
3. Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome Gynecological Endocrinology · 2009 · 64 citations
4. New Perspectives on Nutraceutical Insulin Sensitizing Agents in the Treatment of Psoriasis and Other Dermatological Diseases International Journal of Molecular Sciences · 2025 · 1 citations
5. Myo-inositol in polycystic ovary syndrome: a systematic review and positioning of its use International Journal of Nutrology · 2022 · 1 citations
6. Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women Gynecological Endocrinology · 2009 · 75 citations
7. Metabolic and hormonal effects of a combined Myo-inositol and d-chiro-inositol therapy on patients with polycystic ovary syndrome (PCOS) Ginekologia Polska · 2019 · 19 citations
8. Myo-Inositol (ProFecund Ino) – Obtaining a Pregnancy in Women with Polycystic Ovary Syndrome IntechOpen eBooks · 2024
9. Myo-Inositol to D-Chiro-Inositol ratio in follicular fluid plays a pivotal role for oocyte and embryo quality: summary of available evidence 2020
10. Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review Nutrients · 2021 · 36 citations

Community

— no results